Maria-Pilar Barretina-Ginesta
0000-0003-0074-6614
5 papers found
Refreshing results…
Table S1 from Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)
Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus
SEOM-GEICO clinical guidelines on endometrial cancer (2021)
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial
Missing publications? Search for publications with a matching author name.